.png)
This program is designed specifically for aspiring Clinical Research Associates (CRAs) or entry-level professionals who struggle to land that first job in the clinical trials industry. Getting that first job in the clinical research industry shouldn't feel that hard.
For sure, you've spent months applying to jobs on LinkedIn without any success. That's because you have to target the right people, apply to the right opportunities, with the right messaging. Otherwise, your application will fall into oblivion.
This 6-week program is a combination of educational sessions providing you the knowledge you need to succeed in getting that first job as a clinical research professional, combined with live coaching sessions assessing your CV, your LinkedIn profile and your messaging.
Each week follows with action items that will encourage you to apply the lessons learnt you are getting through this program.
.png)
Maria is a clinical research expert, educator, and the founder of CRAConnect — a global hub empowering Clinical Research Associates through community, education, and networking. She began her career as a Clinical Trial Assistant after transitioning from a linguistics background, and progressed into the CRA role, monitoring studies across oncology, rare diseases, cardiology, CNS, and more. After 5+ years as a CRA, she grew increasingly driven to modernize the tools and processes that shape clinical trials. This led her into the technology side of the industry, where she supported the design, development, and go-to-market strategy of clinical trial software in roles such as Solution Consultant, Subject Matter Expert, and Marketing Director.
With experience across both operations and technology, she founded CRAConnect to address a major gap in the industry: practical, modern, community-driven training for CRAs. Through CRAConnect's Academy, courses, and annual conference, Maria's mission is to elevate the CRA profession and help clinical research professionals learn the real-world skills needed to deliver better trials — and ultimately, better outcomes for patients.




